KMID : 1009020210190040786
|
|
Clinical Psychopharmacology and Neuroscience 2021 Volume.19 No. 4 p.786 ~ p.788
|
|
First Manic Attack During COVID-19 Treatment: A Case Report
|
|
Varsak Nalan
Topaloglu Mert Ozdemir Elif
|
|
Abstract
|
|
|
On March 11, 2020, the World Health Organization declared that the infection of novel coronavirus identified in Wuhan, China, is a pandemic. Various studies have shown that SARS-CoV-2 infection can trigger psychiatric effects such as anxiety, depression, and bipolar disorder. Here, we reported a case with no significant psychiatric history who experienced first-episode mania during the COVID-19 treatment. On the third day of hospitalization, the patient¡¯s mood was elevated, she thought she can treat other patients with her special power, she was talkative and irritable. Olanzapine 20 mg was started and the patient¡¯s score on the Young Mania Rating Scale decreased on the 17th day. Psychiatric outcomes associated with covid 19 are just emerging and it seems likely to be a potential engagement for psychiatric professionals in the future. More studies are required in terms of the treatment, course, and follow-up of psychiatric sequelae in these patients.
|
|
KEYWORD
|
|
COVID-19, Mania, Psychiatry
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|